Clinical parameters associated with collateral development in patients with chronic total coronary occlusion

N W van der Hoeven1, P F Teunissen, G S Werner

  • 1Department of Cardiology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands. nw.vanderhoeven@gmail.com

Insights

Well-developed collaterals in obstructive coronary artery disease (CAD) are linked to survival. This study found that high serum leucocytes and diastolic blood pressure are associated with poorly developed collaterals, while beta blockers may promote better collateralization.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Research

Background:

  • Well-developed collateral circulation is crucial for survival in patients with obstructive coronary artery disease (CAD).
  • Understanding the factors influencing arteriogenesis, the development of new blood vessels, is vital for improving outcomes in CAD patients.
  • Previous studies explored various patient groups, but this research focuses on a unique cohort with chronic total occlusions (CTO).

Purpose of the Study:

  • To identify clinical and laboratory variables associated with arteriogenesis in patients with obstructive coronary artery disease.
  • To investigate factors influencing the collateral flow index (CFI) in a unique cohort of CTO patients.
  • To explore the relationship between specific clinical variables and the development of coronary collaterals.

Main Methods:

  • A pooled analysis of data from 295 chronic total occlusion (CTO) patients across three European centers.
  • Collateral flow index (CFI) was accurately determined using intracoronary pressure measurements, a more precise method than traditional angiography.
  • Multivariate analysis was employed to identify significant clinical and laboratory predictors of CFI.

Main Results:

  • The mean CFI in the study cohort was 0.39 ± 0.14.
  • Multivariate analysis revealed positive associations between beta blockers, hypertension, and angina pectoris duration with CFI.
  • Conversely, high serum leucocytes, prior myocardial infarction, and high diastolic blood pressure were negatively associated with CFI.

Conclusions:

  • High serum leucocytes and high diastolic blood pressure are associated with poorly developed collateral circulation in CTO patients.
  • The use of beta blockers showed a positive association with well-developed collaterals, suggesting a potential role in arteriogenesis.
  • These findings offer new insights into the factors influencing collateral development and the potential mechanisms of beta blockers in CAD management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...